Variation of hepatitis C virus hypervariable region 1 in immunocompromised patients

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 938-943

  Odeberg, Jacob ^b   Yun, Zhibing ^b   Sönnerborg, Anders ^b   Bjøro, Kristian ^b   Uhlén, Mathias ^b   Lundeberg, Joakim ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; GENE SEQUENCE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; VIRUS INFECTIVITY; VIRUS MUTATION;

EID: 0030893672     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513995     Document Type: Article

References (15)

1. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-9.
2. Domingo E, Diez J, Martinez MA, et al. New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. J Gen Virol 1993;74:2039-45.
3. Kurosaki M, Enomoto N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993;18:1293-9.
4. Kato N, Ootsuyama Y, Sekiya H, et al. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 1994;68:4776-84.
5. van Doom LJ, Capriles I, Maertens G, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995;69:773-8.
6. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-72.
7. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994;106:1072-5.
8. Odeberg J, Yun Z, Sönnerborg A, Uhlén M, Lundeberg J. Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing. J Clin Microbiol 1995;33:1870-4.
9. Yun Z, Odeberg J, Lundeberg J, Weiland O, Uhlén M, Sönnerborg A. Restriction of hepatitis C virus heterogeneity during prolonged interferon-α therapy is related to changes in the viral load. J Infect Dis 1996;173:992-6.
10. Bjøro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
11. Leitner T, Halapi E, Scarlatti G, et al. Analysis of heterogeneous viral populations by direct DNA sequencing. Biotechniques 1993;15:120-7.
12. Sällberg M, Ruden U, Wahren B, Magnius LO. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol 1992;30:1989-94.
13. Mink MA, Benichou S, Madaule P, Tiollais P, Prince AM, Inchauspe G. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology 1994;200:246-55.
14. Zhang Z, Chen M, Sönnerborg A, Sällberg M. Anti-HCV NS2 antibody reactivity in relation to HCV serotype, presence of HCV RNA, and HCV infection. Clin Diagn Lab Immunol 1995;1:290-4.
15. Weiner A, Erickson AL, Kansopon J, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-9.